Login
Toggle navigation
Videos
Categories
Trending
Mitek Systems CEO Max Carnecchia discusses the forward outlook and company strategy on TheWatchList with Nicole Petallides.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Scott Carter. Executive Chairman and Interim CEO.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Fiona Dawson on Embracing a Dynamic Mining Career and Promoting Diversity at Newmont
00:10:00
Column Capital: Tailored Financial Solutions for High Net Worth Individuals
00:10:00
Century Global's Strategic Entry into Iron Ore Production with Joyce Lake Project
00:10:00
Five Decades in Construction: Iconic Projects and Milestones of Gayatri Group|Mr. T V Sandeep Kumar Reddy ,Chairman,Gayatri BioOrganics Ltd.
00:10:00
Dr. Heinz Schimmelbusch, CEO of AMG Advanced Metallurgical Group NV, visits Amsterdam and Euronext to mark AMG's special occasion.
00:10:00
Invest Outside of Silicon Valley|Saurabh Gupta,Cofounder And Managing Partner, DST Global
00:10:00
Building a Greener Tomorrow: Insights from the 2022 Aecon Sustainability Panel |Jean-Louis Servranckx - President and CEO of Aecon Group Inc
00:10:00
Biblical Wealth Principles: Nurturing Financial Growth | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
European Metals: Leading Europe's Lithium Revolution from Historic Tin Mines
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Managing Emotions and Avoiding Common Investment Mistakes with Ed Stubbins, CFA and Partner at Fuller & Thaler
00:10:00
Honouring Women in Franchising | Susan Senecal, CEO , A&W Revenue Royalties Income Fund.